Surgery Partners Expands into Dialysis Market with Acquisition of Preferred Vascular Group
- Surgery Partners acquires Preferred Vascular Group, entering the $6 billion dialysis access market with significant growth potential.
- The acquisition strengthens Surgery Partners' service offerings and enhances patient care through PVG's high-quality outpatient services.
- Leadership from PVG will remain post-acquisition, ensuring operational continuity and leveraging Surgery Partners' resources for market impact.
Surgery Partners Expands Focus on Dialysis Care with Strategic Acquisition
Surgery Partners (NASDAQ: SGRY), a key operator within the surgical facility industry, is set to enhance its position in the vascular services market following the recent acquisition of Preferred Vascular Group (PVG). This acquisition, advised by Ziegler, a notable specialty investment bank, allows Surgery Partners entry into the lucrative $6 billion dialysis access market. This sector, which sees over two million procedures performed annually, represents a significant growth opportunity for the company. PVG, established in 2005 and currently operating eight Ambulatory Surgical Centers (ASCs) in Georgia and Ohio, specializes in dialysis access procedures, which are vital for patients requiring these essential treatments.
PVG’s model exemplifies a commitment to high-quality outpatient services, underscored by the operational support of 16 dedicated physicians and a workforce of over 160 employees. By integrating PVG into its portfolio, Surgery Partners not only strengthens its service offerings but also demonstrates a strategic alignment with advancing patient care. The leadership from PVG will remain intact post-acquisition, ensuring continuity in operations and a focused approach on leveraging Surgery Partners’ resources to amplify their market impact. The collaboration aims to enhance clinical outcomes and expand the breadth of vascular services available to patients.
The strategic importance of this acquisition is underscored by insights from Andrew Colbert, Senior Managing Director at Ziegler, who highlights the scalability potential it unlocks for PVG in the national arena. The cooperative effort between Ziegler and PVG has been pivotal in navigating the complexities of the transaction, a sentiment echoed by PVG CEO Dustin Greene, who noted Ziegler's critical advisory role throughout the process. As Surgery Partners seeks to improve patient experiences in the dialysis space, this acquisition marks a definitive step towards greater service innovation and accessibility in outpatient care.
In addition to this acquisition, Ziegler's commitment to providing comprehensive advisory services solidifies its reputation in healthcare investment banking. Their role in this transaction reflects a broader dedication to fostering strategic growth in the healthcare sector.
With continued focus on expanding its vascular service offerings and improving patient outcomes, Surgery Partners positions itself well within the evolving landscape of healthcare delivery, addressing a pressing need for effective dialysis care solutions.
Related Cashu News

HCA Healthcare Raises $3 Billion in Senior Unsecured Notes to Enhance Financial Flexibility
HCA Healthcare successfully completes a public offering of senior unsecured notes totaling US$3.00 billion. This significant move reflects the company’s commitment to bolstering financial flexibility…

IDEXX Laboratories Board Members Show Confidence Through Stock Option Exercises Amid Market Challenges
IDEXX Laboratories (Ticker: IDXX) demonstrates a strong commitment to its future growth as recent insider stock transactions reflect the confidence of its board members. On May 14, several board membe…

Centene Announces Leadership Changes to Strengthen Medicaid and Medicare Operations
Centene Corporation (Ticker: CNC) announces major leadership shifts aimed at boosting its Medicaid and Medicare sectors. These changes could positively impact the company’s strategic direction and ope…

Accuray Partners with University of Wisconsin to Advance Innovative Cancer Therapy Technologies
Accuray Incorporated (Ticker: ARAY) forges a significant decade-long partnership with the University of Wisconsin School of Medicine and Public Health to revolutionize personalized cancer care through…